Align Technology Inc
NASDAQ:ALGN

Watchlist Manager
Align Technology Inc Logo
Align Technology Inc
NASDAQ:ALGN
Watchlist
Price: 164.58 USD 3.51% Market Closed
Market Cap: 11.8B USD

Align Technology Inc
Investor Relations

Align Technology Inc., a pioneer in the orthodontics industry, has revolutionized the way teeth straightening is perceived, moving away from traditional bracketed wire braces to sleek, invisible aligners. Founded in 1997 by Zia Chishti and Kelsey Wirth, the company capitalized on a gap in the market for more aesthetically pleasing orthodontic solutions, ultimately launching its flagship product, Invisalign. Leveraging a combination of 3D computer imaging technology and mass customization, Align Technology creates tailored aligners that gradually move teeth into the desired position. The aligners are not only discreet but also removable, offering a level of convenience that latches onto the desires of image-conscious teens and adults alike.

The company's business model is firmly anchored in both product innovation and strategic marketing. With Invisalign, Align Technology generates revenue by selling its clear aligner systems primarily to orthodontists and general practitioner dentists. The success of their model rests heavily on establishing and maintaining relationships with these dental professionals, who in turn promote the product to patients. Additionally, Align supports its aligners with a suite of digital orthodontic solutions, including the iTero intraoral scanners, which enhance the precision of orthodontic treatments. This integration of proprietary technology with ongoing educational initiatives ensures that Align Technology doesn’t just sell a product, but rather, innovates a comprehensive service that drives sustained brand loyalty and repeat business.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 29, 2025
AI Summary
Q3 2025

Revenue Beat: Q3 2025 revenue was $996 million, up 1.8% year-over-year and above outlook.

Clear Aligner Strength: Clear Aligner volumes and revenue both grew year-over-year, especially in EMEA and APAC regions; teens and kids cases hit a record high.

Margins Exceed Outlook: Non-GAAP operating margin for Q3 was 23.9%, above guidance of 22%.

North America Mixed: North American retail channel remains soft, but DSOs showed strong double-digit growth.

Guidance Raised: Q4 2025 revenue expected at $1.025–$1.045 billion, with sequential growth in Clear Aligner volumes, ASP, and Systems and Services revenues.

Product Innovation: New product launches, including ClinCheck Live Plan and upgrades to iTero, aim to drive efficiency, patient conversion, and digital workflow adoption.

DSO and Financing Growth: DSOs now make up about 25% of business; expanded patient financing through HFD is increasing case starts.

Key Financials
Revenue
$995.7 million
Clear Aligner Revenue
$805.8 million
Clear Aligner Volume
648,000 cases
Clear Aligner Average Selling Price
$1,245
Systems and Services Revenue
$189.9 million
Gross Margin
64.2%
Operating Margin
9.7%
Non-GAAP Operating Margin
23.9%
Net Income per Share (EPS)
$0.78
Non-GAAP Net Income per Share
$2.61
Cash and Cash Equivalents
$1.0046 billion
Free Cash Flow
$169 million
Days Sales Outstanding
101 days
Doctors Submitting Invisalign Cases
88,000
Teen and Kids Cases Started
256,000
Earnings Call Recording
Other Earnings Calls

Management

Mr. Joseph M. Hogan
President, CEO & Director
No Bio Available
Mr. Emory M. Wright
Executive Vice President of Direct Fabrication Platform & Operations
No Bio Available
Mr. Zelko Relic
Executive VP & CTO
No Bio Available
Ms. Shirley Stacy
Vice President of Corporate Communications & Investor Relations
No Bio Available
Ms. Jennifer Olson-Wilk
Executive VP & Chief Customer Officer
No Bio Available
Ms. Sreelakshmi Kolli
Executive VP & Chief Product and Digital Officer
No Bio Available
Mr. Srini Kaza
Executive Vice President of Research & Development
No Bio Available
Mr. Karim Boussebaa
Executive VP & MD of iTero Scanner and Services Business
No Bio Available
Dr. Mitra Derakhshan
Executive Vice President & Chief Clinical Officer
No Bio Available
Mr. David Carr
EVP and MD of the Asia Pacific region
No Bio Available

Contacts

Address
ARIZONA
Tempe
410 North Scottsdale Road, Suite 1300
Contacts
+14084701000.0
www.aligntech.com